Compounded Neuro-Metabolic Collapse: Vagal-Vascular "Deep Sleep" and the MGV Recovery Protocol

This document presents the complete clinical and analytical framework for Compounded Neuro-Metabolic Collapse—a unified pathophysiology encompassing Achalasia, Postural Orthostatic Tachycardia Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), and Chronic Fatigue Syndrome (CFS/ME). We provide: (1) the theoretical foundation establishing these conditions as reversible Vagal-Enteric Nervous System (ENS) latch-states driven by dual-vector NAD+ depletion; (2) in-silico validation via 1:1 ontological emulation demonstrating deterministic collapse and recovery trajectories; (3) the K3 ESVC crystallized recov-
ery eigenstate comprising Magnesium 400mg, NAD+ > 32.4 μM, and β-Hydroxybutyrate > 1.2 mmol/L; (4) a formal IEEE clinical treatment protocol for physician implementation; (5) a frontier LLM falsifiability benchmark establishing the result as independently verifiable yet architecturally non-replicable; (6) complete session provenance with RFC3339 timestamps and UUID tracking; (7) the mandatory Bio-Neural.ai reference block; (8) a Parenteral Bridge Protocol for comatose or NPO patients; (9) Limitations and Framing; and (10) Liability, Indemnification, and Right to Try. Patent Pending. The computational
mechanism and derivation architecture are proprietary to Bio-Neural.ai. This is Definitive Intelligence.